103 related articles for article (PubMed ID: 16382053)
1. A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma.
Leow CC; Polakis P; Gao WQ
Ann N Y Acad Sci; 2005 Nov; 1059():174-83. PubMed ID: 16382053
[TBL] [Abstract][Full Text] [Related]
2. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
4. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
[TBL] [Abstract][Full Text] [Related]
5. Hath1 up-regulates gastric mucin gene expression in gastric cells.
Sekine A; Akiyama Y; Yanagihara K; Yuasa Y
Biochem Biophys Res Commun; 2006 Jun; 344(4):1166-71. PubMed ID: 16647036
[TBL] [Abstract][Full Text] [Related]
6. HATH1 expression in mucinous cancers of the colorectum and related lesions.
Park ET; Oh HK; Gum JR; Crawley SC; Kakar S; Engel J; Leow CC; Gao WQ; Kim YS
Clin Cancer Res; 2006 Sep; 12(18):5403-10. PubMed ID: 17000673
[TBL] [Abstract][Full Text] [Related]
7. Hath1 inhibits proliferation of colon cancer cells probably through up-regulating expression of Muc2 and p27 and down-regulating expression of cyclin D1.
Zhu DH; Niu BL; Du HM; Ren K; Sun JM; Gong JP
Asian Pac J Cancer Prev; 2012; 13(12):6349-55. PubMed ID: 23464457
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study.
Souazé F; Bou-Hanna C; Kandel C; Leclair F; Devallière J; Charreau B; Bézieau S; Mosnier JF; Laboisse CL
PLoS One; 2013; 8(2):e55904. PubMed ID: 23409082
[TBL] [Abstract][Full Text] [Related]
9. [Hath1 gene transfer inhibits the proliferation of colonic cancer cells in vitro].
Zhu DH; Gong JP; Ren K; Sun JM; Wei SD
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1005-8. PubMed ID: 20501407
[TBL] [Abstract][Full Text] [Related]
10. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
Velcich A; Corner G; Palumbo L; Augenlicht L
Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
[TBL] [Abstract][Full Text] [Related]
11. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium.
Gregorieff A; Stange DE; Kujala P; Begthel H; van den Born M; Korving J; Peters PJ; Clevers H
Gastroenterology; 2009 Oct; 137(4):1333-45.e1-3. PubMed ID: 19549527
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
[TBL] [Abstract][Full Text] [Related]
13. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo.
Becker S; Oelschlaeger TA; Wullaert A; Vlantis K; Pasparakis M; Wehkamp J; Stange EF; Gersemann M
PLoS One; 2013; 8(2):e55620. PubMed ID: 23418447
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
Patlolla JM; Swamy MV; Raju J; Rao CV
Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation.
Garg P; Ravi A; Patel NR; Roman J; Gewirtz AT; Merlin D; Sitaraman SV
Gastroenterology; 2007 May; 132(5):1877-89. PubMed ID: 17484881
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer.
Aragaki M; Tsuchiya K; Okamoto R; Yoshioka S; Nakamura T; Sakamoto N; Kanai T; Watanabe M
Biochem Biophys Res Commun; 2008 Apr; 368(4):923-9. PubMed ID: 18275842
[TBL] [Abstract][Full Text] [Related]
17. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
[TBL] [Abstract][Full Text] [Related]
18. Repression of HIP/RPL29 expression induces differentiation in colon cancer cells.
Liu JJ; Huang BH; Zhang J; Carson DD; Hooi SC
J Cell Physiol; 2006 May; 207(2):287-92. PubMed ID: 16475173
[TBL] [Abstract][Full Text] [Related]
19. Numb modulates intestinal epithelial cells toward goblet cell phenotype by inhibiting the Notch signaling pathway.
Yang Y; Zhu R; Bai J; Zhang X; Tian Y; Li X; Peng Z; He Y; Chen L; Ji Q; Chen W; Fang D; Wang R
Exp Cell Res; 2011 Jul; 317(11):1640-8. PubMed ID: 21557937
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
